Ann: Patrys' CEO Presents at Asia Biotech Inv, page-17

re: Ann: Patrys' CEO Presents at Asia Bio... CGT - I just don't see why they would bother to explore plant based systems if associated cost & ease to manufacture didn't slip into it somewhere.


“The exciting and novel data presented in this paper show, for the first time, that functional IgM antibodies can be made efficiently, quickly and highly cost-effectively in a plant-based system. We believe that such a manufacturing system holds real promise for the future and further work in this area is ongoing” said Dr. Frank Hensel, publication author and Vice President of Research and Development at Patrys.

No idea of what actual costs would be but just playing with those figures you put up -

"$200,000 per person out of this world?"

Probably pushing it a bit up that high but there are maybe a handful of drugs above $200K they are more like $300 even up to $400K for Soliris as the worlds most expensive drug but they are for ultra rare diseases.

MM Drugs -

Velcade $80K ?
Kyprolis $120K
Revlimid $150K